Mupirocin Ointment
NDC Package 81033-032-99
Package Information
Mupirocin (mupirocin ointment) ointment is mupirocin is used to treat certain skin infections (such as impetigo). This formulation utilizes a ointment delivery system. Marketed by Kesin Pharma Corporation, this product is identified by NDC 81033-032 and is authorized under FDA application ANDA065123.
Identification & Billing
- RxCUI: 106346 - mupirocin 2 % Topical Ointment
- RxCUI: 106346 - mupirocin 0.02 MG/MG Topical Ointment
- RxCUI: 106346 - mupirocin 20 MG per GM Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 81033 - Kesin Pharma Corporation
- 81033-032 - Mupirocin
- 81033-032-99 - 100 TUBE in 1 BOX / 1 g in 1 TUBE (81033-032-01)
- 81033-032 - Mupirocin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (81033-032). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81033-032-99 identifies a specific commercial package of 100 tube in 1 box / 1 g in 1 tube (81033-032-01) of Mupirocin, a human prescription drug labeled by Kesin Pharma Corporation. This product is billed per "GM" gram and contains an estimated amount of 1 billable units per package. This ointment is formulated for topical use and contains mupirocin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kesin Pharma Corporation on May 28, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Mupirocin is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria.
How is this Kesin Pharma Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81033003299. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.